Efficacy and Safety of PEG-rhG-CSF Injection for Neutrophil Reconstitution Following AHSCT in Lymphoma/Multiple Myeloma
NCT06060080
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
7
Enrollment
OTHER
Sponsor class
Conditions
Lymphoma
Multiple Myeloma
Interventions
DRUG:
pegylated recombinant human granulocyte-colony stimulating factor
Sponsor
Yao Liu